Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06029959 · ClinicalTrials.gov registry record · NA
Stroke and CPAP Outcome Study 3
A NA study of Obstructive Sleep Apnea and Ischemic Stroke, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06029959 is a NA study of Obstructive Sleep Apnea and Ischemic Stroke that has completed, run by University of Washington. The registered enrollment target is 36 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06029959, a NA study of Obstructive Sleep Apnea and Ischemic Stroke, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
A problem with breathing during sleep, called obstructive sleep apnea (OSA), likely increases the risk of stroke and is common in people who have had a stroke, present in about 2/3 of stroke survivors. There is also evidence that OSA predicts worse outcome after stroke. The question being addressed in the Stroke and CPAP Outcome Study 3 (SCOUTS3) is how to improve use of continuous positive airway pressure (CPAP) therapy to treat OSA when started during intensive stroke rehabilitation.
Conditions Studied
Interventions
- DEVICE Continuous positive airway pressure (CPAP)
- BEHAVIORAL Motivational Enhancement Therapy (MET)
- BEHAVIORAL CPAP technical support intervention
- BEHAVIORAL Mobile Health intervention
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06029959
The ClinicalTrials.gov registry entry for NCT06029959 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (84% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 4 interventions - of which Continuous positive airway pressure (CPAP) is the first listed.
NCT06029959 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06029959 about?
NCT06029959 is a clinical study titled "Stroke and CPAP Outcome Study 3". A problem with breathing during sleep, called obstructive sleep apnea (OSA), likely increases the risk of stroke and is common in people who have had a stroke, present in about 2/3 of stroke survivors. There is also evidence that OSA predicts worse outcome after stroke. The question being addressed ...
What is the current status of trial NCT06029959?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2023-10-01. Estimated completion is 2025-01-01.
What conditions does trial NCT06029959 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Ischemic Stroke, Motivation, Adherence, Treatment, Intra Cerebral Hemorrhage.
What interventions are being tested in trial NCT06029959?
The interventions under investigation include: Continuous positive airway pressure (CPAP) (DEVICE), Motivational Enhancement Therapy (MET) (BEHAVIORAL), CPAP technical support intervention (BEHAVIORAL), Mobile Health intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06029959?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06029959 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.